Kura Oncology, Inc. (KURA)
NASDAQ: KURA · Real-Time Price · USD
8.60
+0.14 (1.65%)
At close: Jan 20, 2026, 4:00 PM EST
8.57
-0.03 (-0.32%)
After-hours: Jan 20, 2026, 4:24 PM EST
Kura Oncology Market Cap
Kura Oncology has a market cap or net worth of $748.35 million as of January 20, 2026. Its market cap has increased by 10.49% in one year.
Market Cap
748.35M
Enterprise Value
216.41M
1-Year Change
10.49%
Ranking
Category
Stock Price
$8.60
Market Cap Chart
Since November 5, 2015, Kura Oncology's market cap has increased from $113.70M to $748.35M, an increase of 558.18%. That is a compound annual growth rate of 20.28%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 16, 2026 | 736.20M | -18.57% |
| Dec 31, 2025 | 904.10M | 33.49% |
| Dec 31, 2024 | 677.30M | -36.58% |
| Dec 29, 2023 | 1.07B | 28.64% |
| Dec 30, 2022 | 830.20M | -10.90% |
| Dec 31, 2021 | 931.80M | -49.69% |
| Dec 31, 2020 | 1.85B | 197.24% |
| Dec 31, 2019 | 623.10M | 16.69% |
| Dec 31, 2018 | 534.00M | 15.51% |
| Dec 29, 2017 | 462.30M | 266.61% |
| Dec 30, 2016 | 126.10M | -29.75% |
| Dec 31, 2015 | 179.50M | 57.87% |
| Nov 5, 2015 | 113.70M | - |
View and export this data all the way back to 2015. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 929.76B |
| Johnson & Johnson | 526.82B |
| AbbVie | 378.84B |
| UnitedHealth Group | 299.85B |
| AstraZeneca | 291.69B |
| Novartis AG | 276.38B |
| Merck & Co. | 270.12B |
| Novo Nordisk | 268.23B |